Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors

NCT04446351 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

107

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: GSK6097608
DRUG: Dostarlimab
DRUG: Cobolimab
DRUG: Belrestotug

Sponsor

GlaxoSmithKline

Collaborators

[object Object]
[object Object]